SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001401914-24-000025
Filing Date
2024-04-16
Accepted
2024-04-16 16:20:18
Documents
6
Period of Report
2024-06-05

Document Format Files

Seq Description Document Type Size
1 PRE 14A a2024preliminaryproxystate.htm PRE 14A 579639
2 darebioinlinefullcolorrgbaa.jpg GRAPHIC 130914
3 darebioscienceinc_vxprxyxpb.jpg GRAPHIC 516721
4 darebioscienceinc_vxprxyxpc.jpg GRAPHIC 241390
5 image1a.jpg GRAPHIC 74670
6 imagea.jpg GRAPHIC 103294
  Complete submission text file 0001401914-24-000025.txt   2039277
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36395 | Film No.: 24848069
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)